Wellgistics Health, Inc.(WGRX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $23.3M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
WGRX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Wellgistics Health, Inc. (WGRX), a Consumer Staples sector company. WGRX is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $23.3m in revenue. Based on the latest XBRL financial filings (Q1 2026), Wellgistics Health, Inc. reports quarterly revenue of $1.6M, net income of $-7.7M, free cash flow of $-3.4M. Top institutional holders of WGRX by reported 13-F value include GEODE CAPITAL MANAGEMENT,, VANGUARD CAPITAL MANAGEMENT, VANGUARD FIDUCIARY CO, based on the most recent SEC filings. WGRX trades on the Nasdaq exchange and files with the SEC under CIK 2030763. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate WGRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Wellgistics Health, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$1.6M
Net Income
Q1 2026
$-7.7M
Free Cash Flow
Q1 2026
$-3.4M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+28.7% YoYNet Income
-1377.1% YoYOperating Income
-1425.6% YoYEPS (Diluted)
-853.3% YoYTotal Assets
-46.9% YoYTotal Debt
-26.5% YoYOp. Cash Flow
-786.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $23.3M +28.7% | $18.1M | — | — |
| Net Income | $-101.3M -1377.1% | $-6.9M -136.8% | $-2.9M | — |
| Operating Income | $-93.7M -1425.6% | $-6.1M -113.3% | $-2.9M | — |
| EPS (Diluted) | $-1.43 -853.3% | $-0.15 -150.0% | $-0.06 | — |
| Total Assets | $30.5M -46.9% | $57.3M +16844.1% | $338.4K | — |
| Total Debt | $34.4M -26.5% | $46.8M +13261.7% | $350.0K | — |
| Operating Cash Flow | $-10.9M -786.1% | $-1.2M -250.9% | $-349.1K | — |
AI Insight: WGRX Ratio Trends
Wellgistics faced severe profitability collapse in Q2 2025, with ROIC plunging to -58.9% and negative margins across the board, though leverage fell sharply in Q3 2025.
• Q2 2025 saw operating margin of -70.6% and NPM of -85.6%, indicating substantial operating losses during that quarter.
• Debt-to-equity spiked to 40.28x in Q2 2025 before contracting to 5.46x by Q3 2025, suggesting deleveraging or capital restructuring.
• Q1 2026 ROIC remained deeply negative at -86.3%, the worst return on invested capital in the visible data.
⚠ Persistent negative ROIC through Q1 2026 indicates ongoing value destruction; need clarity on path to profitability.
⚠ Extreme leverage spike in Q2 2025 (40.28x D/E) warrants investigation into debt structure and covenant compliance.
Get alerted when WGRX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Wellgistics Health, Inc. including:
Top Institutional Holders of WGRX
GEODE CAPITAL MANAGEMENT, LLC
$68.5K710,766 shVANGUARD CAPITAL MANAGEMENT LLC
$58.0K604,226 shVANGUARD FIDUCIARY TRUST CO
$29.7K309,584 shSTATE STREET CORP
$12.0K124,600 shJANE STREET GROUP, LLC
$9.1K93,980 shNORTHERN TRUST CORP
$7.1K74,063 shRAYMOND JAMES FINANCIAL INC
$5.6K58,421 shACT Advisors, LLC.
$3.4K35,389 shXTX Topco Ltd
$3.0K31,501 shPoint72 Asset Management, L.P.
$2.6K27,324 sh
| Fund | Value | Shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $68.5K | 710,766 |
| VANGUARD CAPITAL MANAGEMENT LLC | $58.0K | 604,226 |
| VANGUARD FIDUCIARY TRUST CO | $29.7K | 309,584 |
| STATE STREET CORP | $12.0K | 124,600 |
| JANE STREET GROUP, LLC | $9.1K | 93,980 |
| NORTHERN TRUST CORP | $7.1K | 74,063 |
| RAYMOND JAMES FINANCIAL INC | $5.6K | 58,421 |
| ACT Advisors, LLC. | $3.4K | 35,389 |
| XTX Topco Ltd | $3.0K | 31,501 |
| Point72 Asset Management, L.P. | $2.6K | 27,324 |
More Consumer Staples Companies
View all Consumer Staples →Put WGRX on your watchlist
Track score changes the day Wellgistics Health, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is WGRX a good stock to buy?
13F Pro's AI-powered analysis of Wellgistics Health, Inc. (WGRX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for WGRX are available on the WGRX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own WGRX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling WGRX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Wellgistics Health, Inc.'s investment landscape.